Nigel McCracken, chief operating officer, Virax Biolabs, discusses new findings that reveal altered cytokine activity and ...

A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously ...

A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously ...

When your body senses something is wrong—whether it's a damaged cell or a growing tumor—it can react in many ways. One of the ...

Two new studies in Nature report on how effector memory-like CD8 + T cells infiltrate ... hypertrophic organs and find B, T and NK cells and exhausted memory CD4 T cells indicating immune changes ...

CD4-cell counts and T-cell activation levels were determined ... and higher LPS levels were associated with greater activation of CD8 + lymphocytes. CD8 + activation also was found to be higher ...

The research groups led by Wolfgang Kastenmüller and Georg Gasteiger employed innovative microscopy techniques to observe how ...

A supplemental Biologics License Application has been submitted to the FDA for Anktiva plus BCG in papillary NMIBC.

A groundbreaking study published in Research (2025, DOI: 10.34133/research.0545) has elucidated the molecular mechanisms by which protein phosphatase 2A (PP2A) regulates CD8+ T cell-mediated immune ...

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science of addressing critical issues with CAR T cell therapy in patients with ...

1 Blocking the TNF-related apoptosis-inducing ligand (TRAIL) pathway partially reconstitutes HBV-specific T cells, suggesting that these cells are vulnerable to NK cell-mediated apoptosis through this ...